CYTK
Price
$68.15
Change
+$0.60 (+0.89%)
Updated
Nov 26 closing price
Capitalization
8.34B
97 days until earnings call
Intraday BUY SELL Signals
DSGN
Price
$9.37
Change
-$0.04 (-0.43%)
Updated
Nov 26 closing price
Capitalization
534.89M
110 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CYTK vs DSGN

Header iconCYTK vs DSGN Comparison
Open Charts CYTK vs DSGNBanner chart's image
Cytokinetics
Price$68.15
Change+$0.60 (+0.89%)
Volume$1.95M
Capitalization8.34B
Design Therapeutics
Price$9.37
Change-$0.04 (-0.43%)
Volume$416.45K
Capitalization534.89M
CYTK vs DSGN Comparison Chart in %
CYTK
Daily Signal:
Gain/Loss:
DSGN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CYTK vs. DSGN commentary
Nov 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a StrongBuy and DSGN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 28, 2025
Stock price -- (CYTK: $68.15 vs. DSGN: $9.39)
Brand notoriety: CYTK and DSGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 101% vs. DSGN: 140%
Market capitalization -- CYTK: $8.34B vs. DSGN: $534.89M
CYTK [@Biotechnology] is valued at $8.34B. DSGN’s [@Biotechnology] market capitalization is $534.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $109.65B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileDSGN’s FA Score has 0 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • DSGN’s FA Score: 0 green, 5 red.
According to our system of comparison, CYTK is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 4 TA indicator(s) are bullish while DSGN’s TA Score has 6 bullish TA indicator(s).

  • CYTK’s TA Score: 4 bullish, 4 bearish.
  • DSGN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, DSGN is a better buy in the short-term than CYTK.

Price Growth

CYTK (@Biotechnology) experienced а +5.19% price change this week, while DSGN (@Biotechnology) price change was +27.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.76%. For the same industry, the average monthly price growth was -1.24%, and the average quarterly price growth was +71.95%.

Reported Earning Dates

CYTK is expected to report earnings on Mar 04, 2026.

DSGN is expected to report earnings on Mar 17, 2026.

Industries' Descriptions

@Biotechnology (+4.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($8.34B) has a higher market cap than DSGN($535M). DSGN YTD gains are higher at: 52.188 vs. CYTK (44.877). DSGN has higher annual earnings (EBITDA): -74.31M vs. CYTK (-504.83M). CYTK has more cash in the bank: 858M vs. DSGN (216M). DSGN has less debt than CYTK: DSGN (1.95M) vs CYTK (858M). CYTK has higher revenues than DSGN: CYTK (85.7M) vs DSGN (0).
CYTKDSGNCYTK / DSGN
Capitalization8.34B535M1,558%
EBITDA-504.83M-74.31M679%
Gain YTD44.87752.18886%
P/E RatioN/AN/A-
Revenue85.7M0-
Total Cash858M216M397%
Total Debt858M1.95M44,090%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
58
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKDSGN
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 3 days ago
88%
Declines
ODDS (%)
Bearish Trend 8 days ago
78%
Bearish Trend 15 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CYTK
Daily Signal:
Gain/Loss:
DSGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYKAX100.48N/A
N/A
Rydex Banking H
SMBYX41.90N/A
N/A
ClearBridge Mid Cap I
AWTCX19.85N/A
N/A
Virtus Duff & Phelps Water C
WFEAX15.30N/A
N/A
Allspring International Equity A
VZICX33.84N/A
N/A
Vanguard International Core Stock Adm

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with IDYA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-0.21%
IDYA - DSGN
52%
Loosely correlated
+1.13%
CRNX - DSGN
49%
Loosely correlated
+2.93%
WVE - DSGN
48%
Loosely correlated
+3.50%
VRDN - DSGN
48%
Loosely correlated
+0.97%
SYRE - DSGN
48%
Loosely correlated
+1.88%
More